For details see Note [34]
| XLS |
|
|
Equity capital |
Reserves |
|
|
|
| |||
|
EUR million |
General |
Subscribed |
Capital |
Retained |
Actuarial gains and losses |
Gains/ losses |
Equity attributable to share- holders of the parent company |
Non-controlling interest |
Equity |
|
Balance as of January 1, 2009 |
397.2 |
168.0 |
3,813.7 |
4,642.3 |
–90.3 |
574.5 |
9,505.4 |
57.6 |
9,563.0 |
|
Profit after tax |
– |
– |
– |
366.3 |
– |
– |
366.3 |
10.4 |
376.7 |
|
Gains/losses recognized immediately in equity |
– |
– |
– |
– |
–137.8 |
1.7 |
–136.1 |
–4.6 |
–140.7 |
|
Comprehensive income |
– |
– |
– |
366.3 |
–137.8 |
1.7 |
230.2 |
5.8 |
236.0 |
|
Dividend payments |
– |
– |
– |
–96.9 |
– |
– |
–96.9 |
–7.9 |
–104.8 |
|
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–177.8 |
– |
– |
–177.8 |
– |
–177.8 |
|
Changes in scope of consolidation/Other |
– |
– |
– |
–0.2 |
–0.6 |
– |
–0.8 |
–2.0 |
–2.8 |
|
Balance as of December 31, 2009 |
397.2 |
168.0 |
3,813.7 |
4,733.7 |
–228.7 |
576.2 |
9,460.1 |
53.5 |
9,513.6 |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2010 |
397.2 |
168.0 |
3,813.7 |
4,733.7 |
–228.7 |
576.2 |
9,460.1 |
53.5 |
9,513.6 |
|
Profit after tax |
– |
– |
– |
632.1 |
– |
– |
632.1 |
9.4 |
641.5 |
|
Gains/losses recognized immediately in equity |
– |
– |
– |
– |
–141.9 |
704.2 |
562.3 |
5.6 |
567.9 |
|
Comprehensive income |
– |
|
– |
632.1 |
–141.9 |
704.2 |
1,194.4 |
15.0 |
1,209.4 |
|
Dividend payments |
– |
– |
– |
–64.6 |
– |
– |
–64.6 |
–21.5 |
–86.1 |
|
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–261.1 |
– |
– |
–261.1 |
– |
–261.1 |
|
Changes in scope of consolidation/Other |
– |
– |
– |
0.8 |
0.2 |
– |
1.0 |
–5.0 |
–4.0 |
|
Balance as of December 31, 2010 |
397.2 |
168.0 |
3,813.7 |
5,040.9 |
–370.4 |
1,280.4 |
10,329.8 |
42.0 |
10,371.8 |
back
